Peter Collins, Ph.D. – Nature Publishing Group

Peter Collins has been a member of the Board of Nature Publishing Group since 2004 and is currently leading the creation of a Business Intelligence Unit focusing on serving the needs of corporate executives and scientists. Peter’s remit includes products and services focusing on biotechnology, pharmaceuticals, and translational research. Peter has publishing responsibility for Nature MedicineNature BiotechnologyNature Reviews Drug Discovery, and Nature Chemical Biology. Peter and his team are also responsible for the development of products and partnerships that reside at the interface of science and business – such as SciBX with BioCentury and the nature.com open innovation pavilion with Innocentive. Peter is also responsible for Nature Conferences.

After joining the company from Elsevier in 2000 as the launch editor of Nature Reviews Neuroscience, Peter has held various publishing positions and at various times has been responsible for Nature, the Nature research titles, the Nature Reviews titles and sponsorship, display and classified advertising. Peter studied at London University (BSc in applied biology, PhD in neuroscience) and Cambridge University (6 years post-doctoral research).